Sign In
NewsRadar

LibraGen

LibraGen uses functional genomic technologies to develop new bioprocesses for the discovery of novel bioactives and the improvement of production processes of added value molecules.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 

Phone:
Fax:
Web:
Contact:
 
 
Bâtiment Canal Biotech 1
3 rue des Satellites
Toulouse 31400
France
+33 (0)5 6219 3290
+33 (0)5 6173 2756
http://www.libragen.com
Renaud Nalin
+33 (0)5 6219 3290

Company Facts
Founded:Feb 2001
Founders:
CEO:Renaud Nalin
CTO or technical lead:Fabrice Lefèvre
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:Startup
Category:Biotechnology & Healthcare
Sector:Biotechnology
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


26,140
Tech investments
From our Online Data Service
16,888
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Sep 13N/AEnergy related
Sep 13€12.6MConsumer electronics
Sep 12€39.0MBiopharmaceuticals
Sep 12N/AKnowledge management
Sep 12€2.3MInternet commerce
Sep 12€2.1MInternet services
Sep 12€4.0MMedical devices

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.